• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Quris-AI Acquires Nortis to Enhance Bio-AI Platform and Advance Drug Safety Prediction

by Fred Pennic 10/29/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Quris-AI, a leading Bio-AI company revolutionizing drug development, has acquired Nortis, a pioneer in microphysiology systems (MPS) technology, formerly known as Numa Biosciences. 

– The strategic acquisition will integrate Nortis’s advanced Kidney-on-Chip technology into Quris-AI’s Bio-AI platform, enhancing its ability to predict drug safety and efficacy in humans.

Combining Cutting-Edge Technologies

Nortis’s Kidney-on-Chip models have been validated by the National Center for Advancing Translational Sciences (NCATS) and represent a significant advancement in in-vitro drug testing and personalized medicine. By combining this technology with Quris-AI’s machine learning models and patented patient-on-chip system, the company aims to improve the accuracy and efficiency of drug development.

Quris-AI’s Bio-AI Platform: Revolutionizing Drug Development

Quris-AI’s Bio-AI Clinical Prediction Platform is transforming the drug development process by simulating clinical trials and predicting drug responses in humans. This approach reduces the reliance on traditional animal testing and accelerates the identification of promising drug candidates.

The acquisition of Nortis will enable Quris-AI to:

  • Enhance its Bio-AI Platform: Integrate Nortis’s Kidney-on-Chip technology to improve the accuracy of drug safety and efficacy predictions.
  • Advance Drug Development: Accelerate the development of new drugs by identifying and eliminating potentially harmful candidates earlier in the process.
  • Expand Research Collaborations: Continue Nortis’s collaborations with research institutes, the FDA, and pharmaceutical companies to advance kidney disease research.
  • Improve Drug Safety Prediction: Strengthen Quris-AI’s capabilities in predicting drug safety and efficacy in humans.

“We are thrilled to incorporate Nortis’s pioneering technology into the Quris-AI platform,” said Dr. Isaac Bentwich, Founder and CEO of Quris-AI. “This acquisition represents a powerful synergy between Nortis’s legacy of scientific excellence and Quris’s cutting-edge Bio-AI capabilities to significantly enhance the accuracy of drug safety predictions in both pre-clinical and clinical phases. We are dedicated to continuing to push the boundaries of drug safety prediction and personalized medicine, ultimately leading to better patient outcomes and advancing the future of healthcare.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Healthcare Mergers & Acquisitions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |